Q3 EPS Estimates for Henry Schein Lowered by Zacks Research

Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at Zacks Research lowered their Q3 2025 earnings estimates for Henry Schein in a report issued on Thursday, October 17th. Zacks Research analyst R. Department now anticipates that the company will earn $1.35 per share for the quarter, down from their prior forecast of $1.36. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein’s FY2025 earnings at $5.19 EPS, Q3 2026 earnings at $1.39 EPS and FY2026 earnings at $5.67 EPS.

A number of other brokerages also recently issued reports on HSIC. Robert W. Baird decreased their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. JPMorgan Chase & Co. decreased their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Evercore ISI increased their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a report on Friday, September 20th. Finally, Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $77.50.

Henry Schein Trading Up 1.0 %

Shares of HSIC opened at $72.39 on Friday. Henry Schein has a fifty-two week low of $60.01 and a fifty-two week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The company’s fifty day moving average is $70.40 and its 200 day moving average is $69.88. The stock has a market capitalization of $9.27 billion, a PE ratio of 24.46, a P/E/G ratio of 1.98 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. During the same quarter in the prior year, the company posted $1.31 earnings per share. The business’s quarterly revenue was up .0% compared to the same quarter last year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of HSIC. Summit Securities Group LLC purchased a new position in Henry Schein in the second quarter valued at $31,000. Beach Investment Counsel Inc. PA purchased a new stake in Henry Schein in the 2nd quarter worth $37,000. Blue Trust Inc. raised its position in Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after acquiring an additional 475 shares during the period. Mather Group LLC. lifted its holdings in Henry Schein by 16.8% during the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after purchasing an additional 216 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt grew its position in shares of Henry Schein by 282.1% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after purchasing an additional 1,100 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.14% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.